Related Experiment Videos
Adverse effects of bisphosphonates. A comparative review
1Cattedra di Reumatologia, University of Verona, Italy.
Drug Safety
|March 1, 1996
Summary
Bisphosphonates are effective for bone diseases but can cause side effects like fever, renal failure, and gastrointestinal issues. Careful dosing and administration are crucial to manage potential toxicities in patients.
Area of Science:
- Pharmacology
- Bone Biology
- Drug Safety
Background:
- Bisphosphonates are a class of drugs used to treat bone diseases characterized by increased osteoclastic bone resorption.
- These drugs are generally well-tolerated, but toxicity can vary significantly between different compounds.
Purpose of the Study:
- To review the safety and toxicity profile of bisphosphonates.
- To discuss the implications of bisphosphonate use in various patient populations and clinical scenarios.
Main Methods:
- Literature review of bisphosphonate pharmacology and clinical studies.
- Analysis of reported adverse events and toxicity data associated with bisphosphonate therapy.
Main Results:
- High doses of etidronic acid can impair skeletal mineralization and cause fractures.
- Bisphosphonates have a long skeletal half-life but short pharmacological effect.
- Adverse effects include fever, transient hematological changes, potential renal failure with rapid IV injection, and gastrointestinal lesions with oral administration.
Conclusions:
- Bisphosphonates are generally safe and effective for osteoporosis treatment at recommended doses.
- Careful administration, particularly regarding infusion rates and oral intake, is essential to minimize risks.
- Potential toxicities, including impaired mineralization, renal issues, and gastrointestinal problems, require monitoring and dose adjustment.